J Cahn

2.3k total citations
73 papers, 1.3k citations indexed

About

J Cahn is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, J Cahn has authored 73 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Hematology, 10 papers in Molecular Biology and 10 papers in Genetics. Recurrent topics in J Cahn's work include Hematopoietic Stem Cell Transplantation (15 papers), Acute Myeloid Leukemia Research (11 papers) and Neurological Disorders and Treatments (6 papers). J Cahn is often cited by papers focused on Hematopoietic Stem Cell Transplantation (15 papers), Acute Myeloid Leukemia Research (11 papers) and Neurological Disorders and Treatments (6 papers). J Cahn collaborates with scholars based in France, United Kingdom and United States. J Cahn's co-authors include Gèrard Socié, Mohamad Mohty, Régis Peffault de Latour, Gabriel Étienne, Louis Terriou, Sophie Roth, Célia Salanoubat, Sophie de Guibert, Sébastien Maury and Jean Yves Mary and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Stroke.

In The Last Decade

J Cahn

62 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J Cahn France 17 749 415 271 215 179 73 1.3k
B Andersson United States 20 616 0.8× 327 0.8× 214 0.8× 208 1.0× 478 2.7× 39 1.5k
Fiorella Alfinito Italy 18 186 0.2× 338 0.8× 186 0.7× 46 0.2× 65 0.4× 41 794
E Damasio Italy 23 552 0.7× 297 0.7× 472 1.7× 221 1.0× 417 2.3× 65 1.5k
António Almeida Portugal 23 977 1.3× 215 0.5× 679 2.5× 108 0.5× 197 1.1× 79 1.7k
Nathan L. Kobrinsky United States 20 1.1k 1.5× 167 0.4× 269 1.0× 507 2.4× 282 1.6× 58 2.0k
Carella Am Italy 16 572 0.8× 115 0.3× 199 0.7× 133 0.6× 234 1.3× 65 943
R. A. Risdon United Kingdom 15 199 0.3× 91 0.2× 212 0.8× 30 0.1× 89 0.5× 28 872
Peter C. Dau United States 24 205 0.3× 464 1.1× 123 0.5× 22 0.1× 111 0.6× 55 1.7k
W. Mark Brown United States 21 156 0.2× 121 0.3× 42 0.2× 191 0.9× 97 0.5× 49 1.3k
Ronald Rosenburg Germany 8 354 0.5× 160 0.4× 203 0.7× 76 0.4× 83 0.5× 11 1.2k

Countries citing papers authored by J Cahn

Since Specialization
Citations

This map shows the geographic impact of J Cahn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Cahn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Cahn more than expected).

Fields of papers citing papers by J Cahn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J Cahn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Cahn. The network helps show where J Cahn may publish in the future.

Co-authorship network of co-authors of J Cahn

This figure shows the co-authorship network connecting the top 25 collaborators of J Cahn. A scholar is included among the top collaborators of J Cahn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J Cahn. J Cahn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mehta, Rohtesh S., Haris Ali, Voravit Ratanatharathorn, et al.. (2023). A prospective phase 2 clinical trial of a C5a complement inhibitor for acute GVHD with lower GI tract involvement. Bone Marrow Transplantation. 58(9). 991–999. 5 indexed citations
2.
Cleuziou, Julie, P. Chartier, Martin Carré, et al.. (2021). Total body irradiation using helical tomotherapy: Set-up experience and in-vivo dosimetric evaluation. Cancer/Radiothérapie. 25(3). 213–221. 9 indexed citations
3.
Hayashi, Hiromi, Annalisa Ruggeri, Fernanda Volt, et al.. (2018). Chronic graft-versus-host disease features in double unit cord blood transplantation according to National Institutes of Health 2005 cGVHD Consensus criteria. Bone Marrow Transplantation. 53(4). 417–421. 1 indexed citations
4.
5.
Dagher, Marie‐Claire, Anne Gonzalez de Peredo, Julie Mondet, et al.. (2016). Ph− myeloproliferative neoplasm red blood cells display deregulation of IQGAP1-Rho GTPase signaling depending on CALR/JAK2 status. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1863(11). 2758–2765. 6 indexed citations
6.
Bulabois, Claude‐Eric, Anne Thiebaut‐Bertrand, Raphaël Itzykson, et al.. (2014). Alemtuzumab for Severe Steroid-Refractory Gastrointestinal Acute Graft-versus-Host Disease. Biology of Blood and Marrow Transplantation. 20(9). 1451–1454. 13 indexed citations
7.
Alchalby, Haefaa, Tatjana Zabelina, Thomas Stübig, et al.. (2013). Allogeneic Stem Cell Transplantation for Myelofibrosis with Leukemic Transformation: A Study from the Myeloproliferative Neoplasm Subcommittee of the CMWP of the European Group for Blood and Marrow Transplantation. Biology of Blood and Marrow Transplantation. 20(2). 279–281. 56 indexed citations
8.
Garban, Frédéric, Sylvain Carras, Marie‐Christine Jacob, et al.. (2012). Extracorporeal photopheresis as a curative treatment strategy in non epidermotropic T-cell lymphoma and large granular lymphocyte leukemia. Annals of Oncology. 23(9). 2386–2390. 11 indexed citations
9.
Nerich, Virginie, Bruno Lioure, Christian Récher, et al.. (2011). Induction-related cost of patients with acute myeloid leukaemia in France. International Journal of Clinical Pharmacy. 33(2). 191–199. 17 indexed citations
10.
Nicolas, Émmanuelle, Claire Ramus, Sylvie Berthier, et al.. (2010). Expression of S100A8 in leukemic cells predicts poor survival in de novo AML patients. Leukemia. 25(1). 57–65. 46 indexed citations
11.
Carreras, Enric, J Cahn, C. Puozzo, et al.. (2010). Influence on Busilvex pharmacokinetics of clonazepam compared to previous phenytoin historical data.. PubMed. 30(7). 2977–84. 16 indexed citations
12.
Mossuz, Pascal, Marie Arlotto, Sylvie Hermouet, et al.. (2008). Proteomic study of the impact of the JAK2–V617F mutation on the phenotype of essential thrombocythemia. Experimental Hematology. 36(12). 1642–1647. 5 indexed citations
13.
Mossuz, Pascal, Ali Bouamrani, Sabine Brugière, et al.. (2007). Apolipoprotein A1: A new serum marker correlated to JAK2 V617F proportion at diagnosis in patients with polycythemia vera. PROTEOMICS - CLINICAL APPLICATIONS. 1(12). 1605–1612. 8 indexed citations
14.
15.
Tournilhac, Olivier, V. Leblond, Reza Tabrizi, et al.. (2003). Transplantation in Waldenstrom's macroglobulinemia—the French experience. Seminars in Oncology. 30(2). 291–296. 38 indexed citations
16.
Cahn, J, et al.. (1998). [Action of ubiquinone 50 on the cardiovascular system and psychomotor behavior in the dog and rat. Preliminary study].. PubMed. 2. 221–8.
17.
Tiberghien, Pierre, et al.. (1996). Gene transfer applied to the modulation of alloreactivity. PubMed. 38(2). 221–224. 7 indexed citations
18.
Dupont, Jean‐Michel, et al.. (1990). Effect of halothane on ischemic brain edema.. PubMed. 52. 93–6. 3 indexed citations
19.
Cahn, J, et al.. (1988). High Performance Liquid Chromatography of a New 1,4-Dihydropyridine: Applications to Pharmacokinetic Study in Dogs. Journal of Pharmaceutical Sciences. 77(5). 387–389. 11 indexed citations
20.
Cahn, J, M Dubrasquet, Maxime Boucher, & Robert V. Pierre. (1952). [Study of the inhibitor effect of antihistaminics, ganglioplegics and local anesthetics on hyaluronidase].. PubMed. 9(2). 292–7. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by B Andersson Breakdown of academic impact, for papers by Fiorella Alfinito Breakdown of academic impact, for papers by E Damasio Breakdown of academic impact, for papers by António Almeida Breakdown of academic impact, for papers by Nathan L. Kobrinsky Breakdown of academic impact, for papers by Carella Am Breakdown of academic impact, for papers by R. A. Risdon Breakdown of academic impact, for papers by Peter C. Dau Breakdown of academic impact, for papers by W. Mark Brown Breakdown of academic impact, for papers by Ronald Rosenburg
Rankless by CCL
2026